Michael J Goodheart
Overview
Explore the profile of Michael J Goodheart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
1194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonzalez Bosquet J, Wagner V, Polio A, Linder K, Bender D, Goodheart M, et al.
Int J Mol Sci
. 2025 Feb;
26(3).
PMID: 39941116
Women diagnosed with advanced-stage ovarian cancer have a much worse survival rate than women diagnosed with early-stage ovarian cancer, but the early detection of this disease remains a clinical challenge....
2.
Romero I, Lengyel E, Wahner Hendrickson A, Rodriguez G, Leath 3rd C, Rocconi R, et al.
Gynecol Oncol
. 2025 Feb;
194:18-24.
PMID: 39923680
Objective: The primary aim of this study was to determine if metformin, an oral biguanide administered with first-line chemotherapy and continued as maintenance therapy, improves progression-free survival (PFS) for patients...
3.
Gorzelitz J, Adeagbo M, Dungan-Seaver S, Hill E, Kumar A, Goodheart M, et al.
Gynecol Oncol Rep
. 2025 Jan;
57():101659.
PMID: 39811828
Background: Despite recommendations, exercise participation among endometrial cancer survivors remains low. Previous interventions focused on weight loss or in-person programs with limited reach. Regular exercise, regardless of weight change, reduces...
4.
Pennington K, Schlumbrecht M, McGregor B, Goodheart M, Heron L, Zimmerman B, et al.
Contemp Clin Trials
. 2024 Jun;
144:107612.
PMID: 38914309
Background: Ovarian cancer (OC) survivors commonly experience chronic symptoms including anxiety, depression, sleep disturbances, fatigue, physical symptoms, poor health-related quality of life (HRQOL), and a generally poor prognosis. Additionally, factors...
5.
Telles R, Zimmerman M, Thaker P, Slavich G, Ramirez E, Zia S, et al.
Gynecol Oncol
. 2024 Feb;
184:139-145.
PMID: 38309031
Objective: Although rural residence has been related to health disparities in cancer patients, little is known about how rural residence impacts mental health and quality of life (QOL) in ovarian...
6.
Lutgendorf S, Telles R, Whitney B, Thaker P, Slavich G, Goodheart M, et al.
Brain Behav Immun
. 2023 Dec;
116:362-369.
PMID: 38081436
Introduction: Although the concept of hope is highly relevant for cancer patients, little is known about its association with cancer-relevant biomarkers. Here we examined how hope was related to diurnal...
7.
Corvigno S, Badal S, Spradlin M, Keating M, Pereira I, Stur E, et al.
NPJ Precis Oncol
. 2023 Nov;
7(1):115.
PMID: 37923835
In this study, we investigated the metabolic alterations associated with clinical response to chemotherapy in patients with ovarian cancer. Pre- and post-neoadjuvant chemotherapy (NACT) tissues from patients with high-grade serous...
8.
Arshava A, Isaacson A, Goodheart M, Bashir M
JTCVS Tech
. 2023 Oct;
21:109-112.
PMID: 37854803
No abstract available.
9.
Telles R, Zia S, Greteman B, Thaker P, Penedo F, Charlton M, et al.
J Psychosoc Oncol
. 2023 Aug;
42(3):299-314.
PMID: 37587850
Objective: This study was designed to examine (1) whether ovarian cancer (OC) survivors would have greater well-being vs. elevated distress compared to community members during a universal health stressor (COVID-19)...
10.
Gonzalez-Bosquet J, McDonald M, Bender D, Smith B, Leslie K, Goodheart M, et al.
Cancers (Basel)
. 2023 Jul;
15(13).
PMID: 37444425
There are strong correlations between the microbiome and human disease, including cancer. However, very little is known about potential mechanisms associated with malignant transformation in microbiome-associated gynecological cancer, except for...